Metabolic effects of fructose and the worldwide increase in obesity - PubMed (original) (raw)
Review
Metabolic effects of fructose and the worldwide increase in obesity
Luc Tappy et al. Physiol Rev. 2010 Jan.
Free article
Abstract
While virtually absent in our diet a few hundred years ago, fructose has now become a major constituent of our modern diet. Our main sources of fructose are sucrose from beet or cane, high fructose corn syrup, fruits, and honey. Fructose has the same chemical formula as glucose (C(6)H(12)O(6)), but its metabolism differs markedly from that of glucose due to its almost complete hepatic extraction and rapid hepatic conversion into glucose, glycogen, lactate, and fat. Fructose was initially thought to be advisable for patients with diabetes due to its low glycemic index. However, chronically high consumption of fructose in rodents leads to hepatic and extrahepatic insulin resistance, obesity, type 2 diabetes mellitus, and high blood pressure. The evidence is less compelling in humans, but high fructose intake has indeed been shown to cause dyslipidemia and to impair hepatic insulin sensitivity. Hepatic de novo lipogenesis and lipotoxicity, oxidative stress, and hyperuricemia have all been proposed as mechanisms responsible for these adverse metabolic effects of fructose. Although there is compelling evidence that very high fructose intake can have deleterious metabolic effects in humans as in rodents, the role of fructose in the development of the current epidemic of metabolic disorders remains controversial. Epidemiological studies show growing evidence that consumption of sweetened beverages (containing either sucrose or a mixture of glucose and fructose) is associated with a high energy intake, increased body weight, and the occurrence of metabolic and cardiovascular disorders. There is, however, no unequivocal evidence that fructose intake at moderate doses is directly related with adverse metabolic effects. There has also been much concern that consumption of free fructose, as provided in high fructose corn syrup, may cause more adverse effects than consumption of fructose consumed with sucrose. There is, however, no direct evidence for more serious metabolic consequences of high fructose corn syrup versus sucrose consumption.
Similar articles
- Sugar consumption, metabolic disease and obesity: The state of the controversy.
Stanhope KL. Stanhope KL. Crit Rev Clin Lab Sci. 2016;53(1):52-67. doi: 10.3109/10408363.2015.1084990. Epub 2015 Sep 17. Crit Rev Clin Lab Sci. 2016. PMID: 26376619 Free PMC article. Review. - Fructose and metabolic diseases: new findings, new questions.
Tappy L, Lê KA, Tran C, Paquot N. Tappy L, et al. Nutrition. 2010 Nov-Dec;26(11-12):1044-9. doi: 10.1016/j.nut.2010.02.014. Epub 2010 May 14. Nutrition. 2010. PMID: 20471804 Review. - Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial.
Geidl-Flueck B, Hochuli M, Németh Á, Eberl A, Derron N, Köfeler HC, Tappy L, Berneis K, Spinas GA, Gerber PA. Geidl-Flueck B, et al. J Hepatol. 2021 Jul;75(1):46-54. doi: 10.1016/j.jhep.2021.02.027. Epub 2021 Mar 6. J Hepatol. 2021. PMID: 33684506 Clinical Trial. - Fructose and hepatic insulin resistance.
Softic S, Stanhope KL, Boucher J, Divanovic S, Lanaspa MA, Johnson RJ, Kahn CR. Softic S, et al. Crit Rev Clin Lab Sci. 2020 Aug;57(5):308-322. doi: 10.1080/10408363.2019.1711360. Epub 2020 Jan 14. Crit Rev Clin Lab Sci. 2020. PMID: 31935149 Free PMC article. Review.
Cited by
- Exploring Marine-Derived Compounds: In Silico Discovery of Selective Ketohexokinase (KHK) Inhibitors for Metabolic Disease Therapy.
Alturki MS. Alturki MS. Mar Drugs. 2024 Oct 3;22(10):455. doi: 10.3390/md22100455. Mar Drugs. 2024. PMID: 39452863 Free PMC article. - Lactobacillus gasseri BNR17 and Limosilactobacillus fermentum ABF21069 Ameliorate High Sucrose-Induced Obesity and Fatty Liver via Exopolysaccharide Production and β-oxidation.
Jo YM, Son YJ, Kim SA, Lee GM, Ahn CW, Park HO, Yun JH. Jo YM, et al. J Microbiol. 2024 Oct;62(10):907-918. doi: 10.1007/s12275-024-00173-6. Epub 2024 Oct 17. J Microbiol. 2024. PMID: 39417925 - The Impact of Fructose Consumption on Human Health: Effects on Obesity, Hyperglycemia, Diabetes, Uric Acid, and Oxidative Stress With a Focus on the Liver.
Baharuddin B. Baharuddin B. Cureus. 2024 Sep 24;16(9):e70095. doi: 10.7759/cureus.70095. eCollection 2024 Sep. Cureus. 2024. PMID: 39355469 Free PMC article. Review. - Associations of five dietary indices with metabolic dysfunction-associated steatotic liver disease and liver fibrosis among the United States population.
Xu M, Zhan Y, Gao G, Zhu L, Wu T, Xin G. Xu M, et al. Front Nutr. 2024 Aug 16;11:1446694. doi: 10.3389/fnut.2024.1446694. eCollection 2024. Front Nutr. 2024. PMID: 39221157 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical